Establishment and Identification of Patient-Derived Xenograft Model for Oral Squamous Cell Carcinoma

Figure 2

Hematoxylin-eosin staining. (a, c) Primary tumor tissue of the OSCC PDX model (hematoxylin-eosin, 40×, 200×); (b, d) tumor tissue of PDX model of OSCC (hematoxylin-eosin, 40×, 200×).

(a)

(b)

(c)

(d)